-The Hindustan Times To check rising public expenditure, the government's two biggest money-spender schemes - subsidised ration for poor and job guarantee in rural areas - will soon be on the Aadhaar-enabled Direct Benefit Transfer (DBT) platform. The disbursal of subsidy for cooking gas cylinders will come back on the DBT platform after the previous UPA government decided to put it on the hold just before general elections. The UPA, which started transfer...

-Capital Market 14 Crore Soil Health Cards to be Issued in Three Years; Credit Support of Rs. 8 Lakh Crore to Agriculture During 2014-15 Targeted "Finance to 5 lakh joint farming groups of Bhoomi Heen Kisan through NABARD in the current financial year", said Shri Radha Mohan Singh, Agriculture Minister, while inaugurating the National Rabi Conference. Minister said that, a very large number of landless farmers are unable to provide land title...

-The Hindu In addition to adequate provision of funds for cleaning, sanitation training and maintenance of toilets in schools, the issue of fixing accountability must also be addressed The revival of the issue of toilets in schools has brought to the fore a discussion that has for long existed among educationists, with varying positions occupying centre stage at different times. A couple of decades ago, when the deplorable state of education began...

-The Business Standard PlanCom meets this month to hasten implementation; initial focus on target coverage might cover 300 districts After reposing faith in the Aadhaar project at its cabinet meeting last week, the Narendra Modi government wants Direct Benefits Transfer (DBT) to 80% of beneficiaries in five key schemes "as soon as possible". These include the cooking gas subsidy, where DBT was stalled under the previous government. The other schemes are on transfer...

-The Business Standard A ray of hope for Indian generic drug makers Gilead Sciences, the California-headquartered biotechnology company, has authorised seven India-based drug makers - Cipla, Ranbaxy, Mylan, Strides Arcolab, Hetero, Cadila Healthcare and Sequent Scientific - to manufacture and sell the generic versions of its hepatitis C medicine, Sovaldi, in 91 developing countries. Earlier in the week, Lupin, the fourth largest Indian drug maker, announced that it will develop and supply...